Literature DB >> 22134200

Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected by obesogenic diets.

Carolyn E Pritchett1, Andras Hajnal.   

Abstract

The incretin hormone glucagon-like peptide-1 (GLP-1) has been implicated in the regulation of appetite by acting as an anorexigenic gut-brain signal. The postprandial release of GLP-1 can be blunted in obese humans and animals. However, it remains unknown whether obesogenic diets with varying fat and carbohydrate content may differentially influence the effectiveness of GLP-1 feedback. To investigate this, male Sprague-Dawley rats were fed a standard (low fat) chow diet, or one of two high-energy diets varying in fat content (45 or 60 kcal%) for 28 weeks. Intake of sucrose and fructose solutions, two commonly added sugars in the Western diet, was then tested in nondeprived rats following administration of the GLP-1 receptor agonist, Exendin-4 (0, 0.5, 1, 2, 3 µg/kg; s.c.). Exendin-4 dose-dependently reduced short (2 h) sucrose and fructose intake. This effect was significantly attenuated in rats fed more dietary fat, despite both diets resulting in obesity. These findings demonstrate that intake of carbohydrates when offered as treats can be regulated by GLP-1 and suggests that dietary fat consumption, rather than extra calories or obesity, may lead to impaired GLP-1 feedback to curb carbohydrate intake. Future studies are warranted to investigate the relevance of these observations to humans and to elucidate the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134200      PMCID: PMC3603269          DOI: 10.1038/oby.2011.342

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  38 in total

1.  Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

Authors:  Prasanth K Chelikani; Alvin C Haver; Roger D Reidelberger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-02-17       Impact factor: 3.619

2.  Glucagon-like peptide-1: a potent regulator of food intake in humans.

Authors:  J P Gutzwiller; B Göke; J Drewe; P Hildebrand; S Ketterer; D Handschin; R Winterhalder; D Conen; C Beglinger
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 3.  Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress.

Authors:  Ewa Bojanowska
Journal:  Med Sci Monit       Date:  2005-07-25

4.  Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

Authors:  E Näslund; B Barkeling; N King; M Gutniak; J E Blundell; J J Holst; S Rössner; P M Hellström
Journal:  Int J Obes Relat Metab Disord       Date:  1999-03

Review 5.  Glucagon-like peptides.

Authors:  D J Drucker
Journal:  Diabetes       Date:  1998-02       Impact factor: 9.461

6.  Attenuated GLP-1 secretion in obesity: cause or consequence?

Authors:  L R Ranganath; J M Beety; L M Morgan; J W Wright; R Howland; V Marks
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

Review 7.  Gastrointestinal hormones and food intake.

Authors:  April D Strader; Stephen C Woods
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

8.  Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects.

Authors:  Tanja C M Adam; Margriet S Westerterp-Plantenga
Journal:  Br J Nutr       Date:  2005-06       Impact factor: 3.718

Review 9.  Consumption of a high-fat diet alters the homeostatic regulation of energy balance.

Authors:  Stephen C Woods; David A D'Alessio; Patrick Tso; Paul A Rushing; Deborah J Clegg; Stephen C Benoit; Koro Gotoh; Min Liu; Randy J Seeley
Journal:  Physiol Behav       Date:  2004-12-30

10.  Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

Authors:  April D Strader; Torsten P Vahl; Ronald J Jandacek; Stephen C Woods; David A D'Alessio; Randy J Seeley
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-28       Impact factor: 4.310

View more
  5 in total

1.  Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats.

Authors:  Martha C Washington; Thaer R Mhalhal; Ayman I Sayegh
Journal:  Horm Behav       Date:  2016-08-04       Impact factor: 3.587

Review 3.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Fasting glucagon-like peptide 1 concentration is associated with lower carbohydrate intake and increases with overeating.

Authors:  A Basolo; S Heinitz; E J Stinson; B Begaye; M Hohenadel; P Piaggi; J Krakoff; S B Votruba
Journal:  J Endocrinol Invest       Date:  2018-10-03       Impact factor: 4.256

5.  Influences of Dietary Added Sugar Consumption on Striatal Food-Cue Reactivity and Postprandial GLP-1 Response.

Authors:  Hilary M Dorton; Shan Luo; John R Monterosso; Kathleen A Page
Journal:  Front Psychiatry       Date:  2018-01-04       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.